BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 1734286)

  • 1. Novel NADPH-binding domain revealed by the crystal structure of aldose reductase.
    Rondeau JM; Tête-Favier F; Podjarny A; Reymann JM; Barth P; Biellmann JF; Moras D
    Nature; 1992 Jan; 355(6359):469-72. PubMed ID: 1734286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atomic structure of ferredoxin-NADP+ reductase: prototype for a structurally novel flavoenzyme family.
    Karplus PA; Daniels MJ; Herriott JR
    Science; 1991 Jan; 251(4989):60-6. PubMed ID: 1986412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of Escherichia coli thioredoxin reductase refined at 2 A resolution. Implications for a large conformational change during catalysis.
    Waksman G; Krishna TS; Williams CH; Kuriyan J
    J Mol Biol; 1994 Feb; 236(3):800-16. PubMed ID: 8114095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aldose and aldehyde reductases: structure-function studies on the coenzyme and inhibitor-binding sites.
    El-Kabbani O; Old SE; Ginell SL; Carper DA
    Mol Vis; 1999 Sep; 5():20. PubMed ID: 10493777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The crystal structure of the aldose reductase.NADPH binary complex.
    Borhani DW; Harter TM; Petrash JM
    J Biol Chem; 1992 Dec; 267(34):24841-7. PubMed ID: 1447221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure of rat aldose reductase-like protein AKR1B14 holoenzyme: Probing the role of His269 in coenzyme binding by site-directed mutagenesis.
    Sundaram K; Dhagat U; Endo S; Chung R; Matsunaga T; Hara A; El-Kabbani O
    Bioorg Med Chem Lett; 2011 Jan; 21(2):801-4. PubMed ID: 21168333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probing flexibility and "induced-fit" phenomena in aldose reductase by comparative crystal structure analysis and molecular dynamics simulations.
    Sotriffer CA; Krämer O; Klebe G
    Proteins; 2004 Jul; 56(1):52-66. PubMed ID: 15162486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An unlikely sugar substrate site in the 1.65 A structure of the human aldose reductase holoenzyme implicated in diabetic complications.
    Wilson DK; Bohren KM; Gabbay KH; Quiocho FA
    Science; 1992 Jul; 257(5066):81-4. PubMed ID: 1621098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Four crystal structures of the 60 kDa flavoprotein monomer of the sulfite reductase indicate a disordered flavodoxin-like module.
    Gruez A; Pignol D; Zeghouf M; Covès J; Fontecave M; Ferrer JL; Fontecilla-Camps JC
    J Mol Biol; 2000 May; 299(1):199-212. PubMed ID: 10860732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The alrestatin double-decker: binding of two inhibitor molecules to human aldose reductase reveals a new specificity determinant.
    Harrison DH; Bohren KM; Petsko GA; Ringe D; Gabbay KH
    Biochemistry; 1997 Dec; 36(51):16134-40. PubMed ID: 9405046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. X-ray structure of the ferredoxin:NADP+ reductase from the cyanobacterium Anabaena PCC 7119 at 1.8 A resolution, and crystallographic studies of NADP+ binding at 2.25 A resolution.
    Serre L; Vellieux FM; Medina M; Gomez-Moreno C; Fontecilla-Camps JC; Frey M
    J Mol Biol; 1996 Oct; 263(1):20-39. PubMed ID: 8890910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-resolution crystal structure of aldose reductase complexed with the novel sulfonyl-pyridazinone inhibitor exhibiting an alternative active site anchoring group.
    Steuber H; Zentgraf M; Podjarny A; Heine A; Klebe G
    J Mol Biol; 2006 Feb; 356(1):45-56. PubMed ID: 16337231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refined molecular structure of pig pancreatic alpha-amylase at 2.1 A resolution.
    Larson SB; Greenwood A; Cascio D; Day J; McPherson A
    J Mol Biol; 1994 Feb; 235(5):1560-84. PubMed ID: 8107092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aldehyde reductase: the role of C-terminal residues in defining substrate and cofactor specificities.
    Rees-Milton KJ; Jia Z; Green NC; Bhatia M; El-Kabbani O; Flynn TG
    Arch Biochem Biophys; 1998 Jul; 355(2):137-44. PubMed ID: 9675019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-dimensional structure of meso-diaminopimelic acid dehydrogenase from Corynebacterium glutamicum.
    Scapin G; Reddy SG; Blanchard JS
    Biochemistry; 1996 Oct; 35(42):13540-51. PubMed ID: 8885833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Regulation of aldose reductase activity. The influence of effectors on reverse isomerization of the enzyme].
    Pavlov AR; Vartanov SS; Iaropolov AI
    Biokhimiia; 1991 Nov; 56(11):1999-2015. PubMed ID: 1805983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structures of human and porcine aldehyde reductase: an enzyme implicated in diabetic complications.
    El-Kabbani O; Green NC; Lin G; Carson M; Narayana SV; Moore KM; Flynn TG; DeLucas LJ
    Acta Crystallogr D Biol Crystallogr; 1994 Nov; 50(Pt 6):859-68. PubMed ID: 15299353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of porcine aldehyde reductase holoenzyme.
    el-Kabbani O; Judge K; Ginell SL; Myles DA; DeLucas LJ; Flynn TG
    Nat Struct Biol; 1995 Aug; 2(8):687-92. PubMed ID: 7552731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-resolution neutron protein crystallography with radically small crystal volumes: application of perdeuteration to human aldose reductase.
    Hazemann I; Dauvergne MT; Blakeley MP; Meilleur F; Haertlein M; Van Dorsselaer A; Mitschler A; Myles DA; Podjarny A
    Acta Crystallogr D Biol Crystallogr; 2005 Oct; 61(Pt 10):1413-7. PubMed ID: 16204895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The three-dimensional structure of flavodoxin reductase from Escherichia coli at 1.7 A resolution.
    Ingelman M; Bianchi V; Eklund H
    J Mol Biol; 1997 Apr; 268(1):147-57. PubMed ID: 9149148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.